Kidney Cancer (ccRCC) Models

200+ models in China Biobank, 193 in US Biobank. TIL retention demonstrated >4 weeks.

PDO 1.0 & 2.0

H&E, IHC, FACS, NGS

Validated Applications:

  • ICB efficacy evaluation with native TIL retention
  • T-cell activation quantification (CD8+, NK)
  • Drug sensitivity screening